Acerus Pharmaceuticals Corporation Headquarters
Looking for information about Acerus Pharmaceuticals Corporation Headquarters? The links below have collected all the necessary data.
Acerus Pharmaceuticals Corporation - About Us
- https://www.aceruspharma.com/English/about-us/default.aspx
- I look forward to sharing more about our corporate strategy and progress on our achievements over the coming months! Sincerely, Edward Gudaitis President & Chief Executive Officer Acerus Pharmaceuticals Corporation. Acerus Pharmaceuticals Corporation 2486 Dunwin Dr, Mississauga, ON L5L 1J9. T:(416) 679-0771 F:(905) 569-1809
Acerus Pharmaceuticals Corporation - Home
- http://www.aceruspharma.com/English/home/
- Jun 14, 2021 · August 12, 2021 Acerus Reports Acceptance of Part 36 Settlement Offer in Recipharm Litigation August 10, 2021 Acerus Reports Fiscal 2021 Second Quarter Financial Results August 3, 2021 Acerus to Report Q2-2021 Financial Results and Host Investor Call
Acerus Pharmaceuticals - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/acerus-pharmaceuticals-corporation
- Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in the United States and.
Acerus Pharmaceuticals Corp. - Relationship Science
- https://relationshipscience.com/organization/acerus-pharmaceuticals-corp-1844305
- Aug 17, 2020 · Acerus Pharmaceuticals Corp. engages in the development, manufacture, production, marketing, and distribution of women's and men's health products. It focuses on therapeutics for urology, hormone replacement therapy, and female dysfunction. Its …
Acerus Pharmaceuticals - Overview, News & Competitors ...
- https://www.zoominfo.com/c/acerus-pharmaceuticals-corporation/370693654
- Acerus Reports Acceptance of Part 36 Settlement Offer in Recipharm Litigation TORONTO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today announced that it had accepted a Part 36 settlement offer made by Recipharm Limited (“Recipharm”), a wholly-owned subsidiary of Recipharm AB.Employees: 11
Acerus Pharmaceuticals Company Profile: Stock Performance ...
- https://pitchbook.com/profiles/company/59652-73
- Acerus Pharmaceuticals Corp is a specialty pharmaceutical company. Principally, it is engaged in the development, manufacture, marketing, and distribution of branded products in men's and women's health. The company markets its product under brand ESTRACE, NATESTO, GYNOFLOR and TEFINA.
Acerus Pharmaceuticals Corporation - About Us - Board of ...
- http://www.aceruspharma.com/English/about-us/board-of-directors/person-details/default.aspx?ItemId=c6cc5d8b-4ca4-4f1d-98eb-25696efec187
- Prior to joining Acerus, Mr. Hickey was Sr. Director of Marketing, Sleep Medicine, for Jazz Pharmaceuticals (NASDAQ: JAZZ). In this role, he was responsible for the successful US launch of SUNOSI®, overseeing all disease awareness and branded efforts for Jazz’ first retail pharmaceutical …
Have you found Acerus Pharmaceuticals Corporation Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.